SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GKB Ophthalmics board to consider dividend

13 May 2016 Evaluate

GKB Ophthalmics has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2016 and to recommend dividend, if any. Further, the Trading Window which was closed with effect from April 01, 2016 shall re-open on June 01, 2016.

The above information is a part of company’s filings submitted to BSE.

GKB Ophthalmics Share Price

72.28 -2.57 (-3.43%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 549.10
Poly Medicure 1452.35
Laxmi Denta 190.85
Nureca Ltd. 257.75
Hemant Surgical Inds 296.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×